Kailera Therapeutics KLRA
NASDAQ KLRA
$13.27 +0.06 (+0.45%)
At close: Nov 13, 2026 · 4:00 PM EST

Kailera Therapeutics (KLRA) Shares Repurchased (2026)

Updated

Kailera Therapeutics (KLRA) posted Shares Repurchased of -$7.92 million for Q2 2026.

Analysis

Kailera Therapeutics (KLRA) Shares Repurchased (2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Shares Repurchased at Kailera Therapeutics was -$4.88 million; for FY2025, it came in at -$315,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 377.00 Mn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 1.71 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 5.00 Mn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 653.00 Mn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 370.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Kailera Therapeutics 1.72 Bn -1.16 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -7.92 Mn
Mar 31, 2026 3.04 Mn
API Access

Kailera Therapeutics Shares Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-repurchased&ticker=KLRA&period=max&api_key=YOUR_API_KEY